Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.sutrobio.com save search
41st Annual JP Morgan Healthcare Conference – Presentation
Published: 2023-01-12 (Crawled : 19:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
| Email alert
Add to watchlist
conference presentation
Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation
Published: 2023-01-09 (Crawled : 23:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 for program trial presentation update cancer
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Published: 2023-01-09 (Crawled : 22:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: -0.3%
H: 1.79%
C: 0.35%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 biopharma update cancer study
Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 13:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -0.06%
H: 4.31%
C: -0.37%
biopharma conference
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
Published: 2022-12-21 (Crawled : 13:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 5.16%
H: 3.45%
C: 3.2%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -6.79%
H: 1.43%
C: 0.0%
stro-002 biopharma for update cancer
Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract
Published: 2022-12-20 (Crawled : 22:00) - sutrobio.com
PPRUF | News | $589.6 0
|
Consumer Non-Durables
|
| O: 2.83%
H: 2.66%
C: -0.36%
PPRUY | News | $59.465 0
|
Manufacturing
|
| O: 1.46%
H: 1.58%
C: 0.82%
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 5.16%
H: 3.45%
C: 3.2%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -6.79%
H: 1.43%
C: 0.0%
biopharma for grant agreement
64th American Society of Hematology Annual Meeting and Exposition – Non-Audio Presentation
Published: 2022-12-10 (Crawled : 00:20) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
| Email alert
Add to watchlist
meeting presentation
Sutro Biopharma to Participate in Upcoming Investor Conferences
Published: 2022-11-23 (Crawled : 12:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: 0.0%
biopharma
Jefferies London Healthcare Conference – Presentation
Published: 2022-11-17 (Crawled : 05:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -1.07%
H: 0.67%
C: -0.27%
conference presentation
37th Annual Meeting Society for Immunotherapy of Cancer (SITC) 2022 – Abstracts
Published: 2022-11-11 (Crawled : 23:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
| Email alert
Add to watchlist
immunotherapy for meeting cancer
Credit Suisse 31st Annual Healthcare Conference – Presentation
Published: 2022-11-09 (Crawled : 12:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -2.48%
H: 4.67%
C: 0.82%
conference presentation
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Published: 2022-11-08 (Crawled : 22:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: -1.05%
H: 2.21%
C: -2.28%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -2.48%
H: 4.67%
C: 0.82%
biopharma financial
64th American Society of Hematology Annual Meeting and Exposition – Abstract
Published: 2022-11-03 (Crawled : 14:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -4.11%
H: 7.61%
C: 1.94%
meeting
Sutro Biopharma to Participate in Upcoming Investor Conferences
Published: 2022-11-02 (Crawled : 11:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
biopharma
Sutro Biopharma Announces Departure of Chief Medical Officer
Published: 2022-10-24 (Crawled : 11:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 60.83%
H: 2.7%
C: -6.12%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 3.84%
H: 14.96%
C: 13.91%
biopharma
2022 Wells Fargo Healthcare Conference – Presentation
Published: 2022-09-09 (Crawled : 15:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 0.0%
H: 1.03%
C: -0.17%
conference presentation
Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference
Published: 2022-09-01 (Crawled : 11:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: -1.32%
H: 0.02%
C: -1.49%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: -3.42%
H: 4.26%
C: 4.08%
biopharma conference
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-08-19 (Crawled : 20:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
| Email alert
Add to watchlist
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
| Email alert
Add to watchlist
biopharma nasdaq grants
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
Published: 2022-08-08 (Crawled : 21:00) - sutrobio.com
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
| Email alert
Add to watchlist
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
| Email alert
Add to watchlist
biopharma
Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference
Published: 2022-08-03 (Crawled : 11:00) - sutrobio.com
PCVX | $46.17 -1.54% -1.56% 350K
|
Health Technology
|
| O: 4.48%
H: 4.04%
C: 0.99%
STRO | $7.51 0.27% 0.27% 290K
|
Health Technology
|
| O: 1.08%
H: 6.22%
C: -4.62%
biopharma conference
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.